文献速递肝病

肝巨噬细胞维生素D受体激活改善小鼠肝脏炎症、脂肪变性与胰岛素抵抗

Vitamin D Receptor Activation in Liver Macrophages Ameliorates Hepatic Inflammation, Steatosis, and Insulin Resistance in Mice.
PubMed 文献 · Hepatology · 2020-02-23

该研究在饮食诱导肥胖(DIO)小鼠模型中探讨肝巨噬细胞维生素D受体(VDR)激活的作用。结果显示,维生素D类似物卡泊三醇激活VDR可减轻肝脏炎症和脂肪变性,并通过高胰岛素-正葡萄糖钳夹试验证实主要改善肝脏胰岛素敏感性;氯膦酸盐脂质体清除肝巨噬细胞后该益处消失,表明肝巨噬细胞VDR激活是抗糖尿病效应所必需。

要点

  • 肝巨噬细胞VDR激活可减轻DIO小鼠肝脏炎症和脂肪变性。
  • VDR激活改善胰岛素敏感性主要通过增加葡萄糖输注率、降低肝糖输出。
  • 肝巨噬细胞VDR激活是卡泊三醇代谢获益的必要条件。

核心结论

  • 维生素D配体激活肝巨噬细胞VDR可改善肝脏炎症、脂肪变性和胰岛素抵抗。

研究设计与样本

  • 研究使用饮食诱导肥胖(DIO)小鼠模型,并结合Vdr基因敲除小鼠及氯膦酸盐脂质体清除肝巨噬细胞实验。

主要发现

  • VDR激活在DIO小鼠肝巨噬细胞中显示强抗炎效应;Vdr基因缺失小鼠在6月龄时自发出现肝脏炎症。
  • 卡泊三醇激活VDR减轻肝脏炎症和脂肪变性,显著改善胰岛素敏感性。
  • 高胰岛素-正葡萄糖钳夹显示VDR激活大幅增加葡萄糖输注率,同时肝糖生成显著降低;肌肉和脂肪葡萄糖摄取无类似效应。
  • 氯膦酸盐脂质体清除肝巨噬细胞后,卡泊三醇的代谢益处基本消失。

临床怎么用

  • 提示靶向肝巨噬细胞VDR可能成为NAFLD和2型糖尿病的治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Obesity-induced chronic inflammation is a key component in the pathogenesis of nonalcoholic fatty liver disease (NAFLD) and insulin resistance. Increased secretion of proinflammatory cytokines by macrophages in metabolic tissues promotes disease progression. In the diet-induced obesity (DIO) mouse model, activation of liver resident macrophages, or Kupffer cells (KCs), drives inflammatory responses, which recruits circulating macrophages and promotes fatty liver development, and ultimately contributes to impaired hepatic insulin sensitivity. Hepatic macrophages express the highest level of vitamin D receptors (VDRs) among nonparenchymal cells, whereas VDR expression is very low in hepatocytes. VDR activation exerts anti-inflammatory effects in immune cells. APPROACH AND RESULTS: Here we found that VDR activation exhibits strong anti-inflammatory effects in mouse hepatic macrophages, including those isolated from DIO livers, and mice with genetic loss of Vdr developed spontaneous hepatic inflammation at 6 months of age. Under the chronic inflammation conditions of the DIO model, VDR activation by the vitamin D analog calcipotriol reduced liver inflammation and hepatic steatosis, significantly improving insulin sensitivity. The hyperinsulinemic euglycemic clamp revealed that VDR activation greatly increased the glucose infusion rate, while hepatic glucose production was remarkably decreased. Glucose uptake in muscle and adipose did not show similar effects, suggesting that improved hepatic insulin sensitivity is the primary contributor to the beneficial effects of VDR activation. Finally, specifically ablating liver macrophages by treatment with clodronate liposomes largely abolished the beneficial metabolic effects of calcipotriol, confirming that VDR activation in liver macrophages is required for the antidiabetic effect. CONCLUSIONS: Activation of liver macrophage VDRs by vitamin D ligands ameliorates liver inflammation, steatosis and insulin resistance. Our results suggest therapeutic paradigms for treatment of NAFLD and type 2 diabetes mellitus.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Dong B, Zhou Y, Wang W, et al. Vitamin D Receptor Activation in Liver Macrophages Ameliorates Hepatic Inflammation, Steatosis, and Insulin Resistance in Mice. Hepatology. 2020. PMID: 31506976. doi:10.1002/hep.30937

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。